Usefulness of (18)F‐fluorodeoxyglucose positron emission tomography/computed tomography for predicting the prognosis and treatment response of neoadjuvant therapy for pancreatic ductal adenocarcinoma

BACKGROUND: The Response Evaluation Criteria in Solid Tumors (RECIST) for computed tomography (CT) is preoperatively used to evaluate therapeutic effects. However, it does not reflect the pathological treatment response (PTR) of pancreatic ductal adenocarcinoma (PDAC). The Positron Emission Tomograp...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Cancer Med
Κύριοι συγγραφείς: Yokose, Takahiro, Kitago, Minoru, Matsusaka, Yohji, Masugi, Yohei, Shinoda, Masahiro, Yagi, Hiroshi, Abe, Yuta, Oshima, Go, Hori, Shutaro, Endo, Yutaka, Toyama, Kenji, Iwabuchi, Yu, Takemura, Ryo, Ishii, Ryota, Nakahara, Tadaki, Okuda, Shigeo, Jinzaki, Masahiro, Kitagawa, Yuko
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: John Wiley and Sons Inc. 2020
Θέματα:
Clinical Cancer Research
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7300404/
https://ncbi.nlm.nih.gov/pubmed/32281301
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.3044
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια